Polish Govt OKs Two Pharma Privatizations

16 September 1997

The Polish government has given its approval to the privatization of twodrug firms. It is to sell a 70% stake in Krakowskie Zaklady Farmaceutycne Polfa to investors who won a public tender announced in January, and a similar 70% stake in Przedsiebiorstwo Farmaceutycne Polfa wRzeszowie is to be made available.

Concerning the latter, it was announced that Polfa Rzeszow would be sold to an investor that guaranteed the development of the firm, though the government added that it would still continue to hold control over the company for 10 years, through special shares.

Both Firms Attracting Investors Although the government has declined to name the investors, Reuters reported that in May, a Polish newspaper quoted unnamed sources as saying that Merck, Hoechst Marion Roussel and ICN Pharmaceutical had each submitted binding offers for shares in Polfa Rzeszow.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight